Abstract
The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 247-257 |
| Number of pages | 11 |
| Journal | European Heart Journal |
| Volume | 38 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2017 |
Fingerprint
Keywords
- ICD implant
- Subcutaneous implantable cardioverter defibrillator
- Sudden cardiac death
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
The subcutaneous implantable cardioverter defibrillator : State-of-the-art review. / McLeod, Christopher J.; Boersma, Lucas; Okamura, Hideo; Friedman, Paul Andrew.
In: European Heart Journal, Vol. 38, No. 4, 2017, p. 247-257.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - The subcutaneous implantable cardioverter defibrillator
T2 - State-of-the-art review
AU - McLeod, Christopher J.
AU - Boersma, Lucas
AU - Okamura, Hideo
AU - Friedman, Paul Andrew
PY - 2017
Y1 - 2017
N2 - The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.
AB - The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.
KW - ICD implant
KW - Subcutaneous implantable cardioverter defibrillator
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=85015666738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85015666738&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehv507
DO - 10.1093/eurheartj/ehv507
M3 - Review article
C2 - 28182222
AN - SCOPUS:85015666738
VL - 38
SP - 247
EP - 257
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 4
ER -